P53 OVEREXPRESSION IN FORMALIN-FIXED, PARAFFIN-EMBEDDED TISSUE DETECTED BY IMMUNOHISTOCHEMISTRY

被引:119
作者
KERNS, BJM
JORDAN, PA
MOORE, MBH
HUMPHREY, PA
BERCHUCK, A
KOHLER, MF
BAST, RC
IGLEHART, JD
MARKS, JR
机构
[1] DUKE UNIV,MED CTR,DEPT PATHOL,DURHAM,NC 27710
[2] DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710
[3] DUKE UNIV,MED CTR,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,DURHAM,NC 27710
[4] DUKE UNIV,MED CTR,DUKE COMPREHENS CANC CTR,DURHAM,NC 27710
关键词
P53; IMMUNOHISTOCHEMISTRY; ABC TECHNIQUE;
D O I
10.1177/40.7.1607637
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mutation and overexpression of the p53 gene have been noted in a wide range of human cancers and are thought to play a role in malignant transformation. Previously, immunohistochemical detection of p53 has been possible only in fresh-frozen tissues. We examined p53 expression in paraffin-embedded tissues from 50 epithelial ovarian cancers and 25 primary breast cancers with a modified immunohistochemical (IHC) technique developed in this laboratory, using monoclonal antibody (MAb) PAb1801. The 75 cases were selected from a group of patients in whom the expression levels had already been assessed in a fresh-tissue IHC assay. An identical staining reactivity was observed in both formalin-fixed, paraffin-embedded tissue and fresh-frozen tissue in 48 of 50 (96%) epithelial ovarian cancers and in 23 of 25 (92%) primary breast cancers. Immunodetection of p53 in paraffin-embedded tissue blocks will be a useful alternative to the standard fresh-tissue assay and can accurately reflect the level of p53 expression in human tumors.
引用
收藏
页码:1047 / 1051
页数:5
相关论文
共 18 条
  • [1] ISOLATION OF HUMAN-P53-SPECIFIC MONOCLONAL-ANTIBODIES AND THEIR USE IN THE STUDIES OF HUMAN P53 EXPRESSION
    BANKS, L
    MATLASHEWSKI, G
    CRAWFORD, L
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 159 (03): : 529 - 534
  • [2] PATTERNS OF EXPRESSION OF THE P53 TUMOR SUPPRESSOR IN HUMAN BREAST TISSUES AND TUMORS INSITU AND INVITRO
    BARTEK, J
    BARTKOVA, J
    VOJTESEK, B
    STASKOVA, Z
    REJTHAR, A
    KOVARIK, J
    LANE, DP
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (05) : 839 - 844
  • [3] DAVIDOFF AM, 1991, CANCER RES, V51, P2605
  • [4] ACTIVATING MUTATIONS FOR TRANSFORMATION BY P53 PRODUCE A GENE-PRODUCT THAT FORMS AN HSC70-P53 COMPLEX WITH AN ALTERED HALF-LIFE
    FINLAY, CA
    HINDS, PW
    TAN, TH
    ELIYAHU, D
    OREN, M
    LEVINE, AJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (02) : 531 - 539
  • [5] P53 MUTATIONS IN HUMAN CANCERS
    HOLLSTEIN, M
    SIDRANSKY, D
    VOGELSTEIN, B
    HARRIS, CC
    [J]. SCIENCE, 1991, 253 (5015) : 49 - 53
  • [6] USE OF AVIDIN-BIOTIN-PEROXIDASE COMPLEX (ABC) IN IMMUNOPEROXIDASE TECHNIQUES - A COMPARISON BETWEEN ABC AND UNLABELED ANTIBODY (PAP) PROCEDURES
    HSU, SM
    RAINE, L
    FANGER, H
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1981, 29 (04) : 577 - 580
  • [7] KOHLER MF, 1992, CANCER RES, V52, P1622
  • [8] OLIGOMERIZATION OF ONCOPROTEIN-P53
    KRAISS, S
    QUAISER, A
    OREN, M
    MONTENARH, M
    [J]. JOURNAL OF VIROLOGY, 1988, 62 (12) : 4737 - 4744
  • [9] THE P53 TUMOR SUPPRESSOR GENE
    LEVINE, AJ
    MOMAND, J
    FINLAY, CA
    [J]. NATURE, 1991, 351 (6326) : 453 - 456
  • [10] MARKS JR, 1991, CANCER RES, V51, P2979